Skip to content
Therapy But Better – Lifestyle
Author:
Kyverna Therapeutics, Inc.
Kyverna Therapeutics Highlights Updated Miv-cel Data at EULAR Demonstrating Substantial Reduction in Disease Activity in ACPA-Positive, Treatment Refractory Rheumatoid Arthritis
June 3, 2026
Kyverna Therapeutics Names Greg Martini as Chief Financial Officer
May 18, 2026
Kyverna Therapeutics to Present at Upcoming Investor Conferences
May 14, 2026
←
Previous Page
1
2